Sponsor:
Iterion Therapeutics
Code:
NCT05797805
Conditions
Advanced Hepatocellular Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tegavivint
Lenvatinib
Cabozantinib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-17. This information was provided to ClinicalTrials.gov by Iterion Therapeutics on 2025-07-04.